Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome

Polycystic ovary (PCO) syndrome is strongly associated with insulin resistance and the accompanying adverse metabolic profile. To distinguish the mechanisms of this association, we determined the interactions of PCO with obesity and the influence of ameliorating direct androgenic actions via short-t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Metabolism, clinical and experimental clinical and experimental, 1995-04, Vol.44 (4), p.525-531
Hauptverfasser:	Diamanti-Kandarakis, Evanthia, Mitrakou, Asimina, Hennes, Magda M.I., Platanissiotis, Dimitris, Kaklas, Nicholas, Spina, Jovanna, Georgiadou, Elli, Hoffmann, Raymond G., Kissebah, Ahmed H., Raptis, Sotos
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Androgen Antagonists - therapeutic use Androgens - blood Biological and medical sciences Female Female genital diseases Flutamide - therapeutic use Gynecology. Andrology. Obstetrics Humans Insulin Resistance Medical sciences Obesity - complications Obesity - physiopathology Polycystic Ovary Syndrome - complications Polycystic Ovary Syndrome - drug therapy Polycystic Ovary Syndrome - physiopathology Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!